“…In May 2018, patient A, a previously healthy man aged 30 years, was evaluated at a District of Columbia (DC) health care facility for a 4-day history of chills, diarrhea, fever (103°F [39.5°C]), headache, sore throat, and vomiting. Despite symptomatic treatment with antipyretics, he subsequently experienced hemoconcentration (hematocrit = 60.4% [normal = 38.8%–50%]), thrombocytopenia (<10,000 platelets/ μ L [normal = 150,000–450,000]), and acute kidney injury (blood urea nitrogen [BUN] = 95 mg/dL [normal = 9–20] and creatinine = 4.95 mg/dL [normal = 0.66–1.50]) over several days ( 1 ). Approximately 1 week later, he experienced signs consistent with hemophagocytic lymphohistiocytosis, a potentially fatal systemic inflammatory syndrome, including elevated ferritin, triglycerides, and interleukin-2 levels, and hemophagocytosis cells on bone marrow biopsy ( 2 ).…”